Welcome to the Craven Lab
Led by Gregory Craven, we design small molecule inhibitors and chemical tools to probe and perturb dysregulated signaling pathways, especially in cancer.
Our interdisciplinary research combines:
- Small-molecule design and synthesis
- Proteomic mass spectrometry
- Structural biology and biochemistry
We like to exploit covalent inhibition, stereochemistry, and metal-binding to uncover new biology and inform therapeutic strategies in cancer.